ALPHATEC HOLDINGS INC (ATEC)

US02081G2012 - Common Stock

10.06  -0.15 (-1.47%)

After market: 10.06 0 (0%)

Fundamental Rating

2

ATEC gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 187 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of ATEC have multiple concerns. ATEC is quite expensive at the moment. It does show a decent growth rate.



1

1. Profitability

1.1 Basic Checks

In the past year ATEC has reported negative net income.
In the past year ATEC has reported a negative cash flow from operations.
In the past 5 years ATEC always reported negative net income.
In the past 5 years ATEC always reported negative operating cash flow.

1.2 Ratios

Looking at the Return On Assets, with a value of -23.85%, ATEC is in line with its industry, outperforming 49.20% of the companies in the same industry.
Looking at the Return On Equity, with a value of -799.73%, ATEC is doing worse than 89.84% of the companies in the same industry.
Industry RankSector Rank
ROA -23.85%
ROE -799.73%
ROIC N/A
ROA(3y)-25.87%
ROA(5y)-28.28%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

ATEC has a better Gross Margin (69.47%) than 80.21% of its industry peers.
ATEC's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for ATEC so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 69.47%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.12%
GM growth 5Y-1.37%

2

2. Health

2.1 Basic Checks

ATEC does not have a ROIC to compare to the WACC, probably because it is not profitable.
ATEC has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, ATEC has more shares outstanding
ATEC has a better debt/assets ratio than last year.

2.2 Solvency

Based on the Altman-Z score of -0.67, we must say that ATEC is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of -0.67, ATEC perfoms like the industry average, outperforming 40.64% of the companies in the same industry.
A Debt/Equity ratio of 23.65 is on the high side and indicates that ATEC has dependencies on debt financing.
ATEC's Debt to Equity ratio of 23.65 is on the low side compared to the rest of the industry. ATEC is outperformed by 91.44% of its industry peers.
Industry RankSector Rank
Debt/Equity 23.65
Debt/FCF N/A
Altman-Z -0.67
ROIC/WACCN/A
WACC8.36%

2.3 Liquidity

A Current Ratio of 2.32 indicates that ATEC has no problem at all paying its short term obligations.
ATEC has a Current ratio of 2.32. This is in the lower half of the industry: ATEC underperforms 60.96% of its industry peers.
ATEC has a Quick Ratio of 1.15. This is a normal value and indicates that ATEC is financially healthy and should not expect problems in meeting its short term obligations.
ATEC's Quick ratio of 1.15 is on the low side compared to the rest of the industry. ATEC is outperformed by 71.66% of its industry peers.
Industry RankSector Rank
Current Ratio 2.32
Quick Ratio 1.15

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 15.23% over the past year.
The Revenue has grown by 27.22% in the past year. This is a very strong growth!
ATEC shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 39.37% yearly.
EPS 1Y (TTM)15.23%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%20%
Revenue 1Y (TTM)27.22%
Revenue growth 3Y49.3%
Revenue growth 5Y39.37%
Sales Q2Q%27.44%

3.2 Future

Based on estimates for the next years, ATEC will show a very strong growth in Earnings Per Share. The EPS will grow by 25.25% on average per year.
ATEC is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 18.68% yearly.
EPS Next Y28.61%
EPS Next 2Y25.43%
EPS Next 3Y21.07%
EPS Next 5Y25.25%
Revenue Next Year27.38%
Revenue Next 2Y23.94%
Revenue Next 3Y22.19%
Revenue Next 5Y18.68%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ATEC. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ATEC. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as ATEC's earnings are expected to grow with 21.07% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y25.43%
EPS Next 3Y21.07%

0

5. Dividend

5.1 Amount

No dividends for ATEC!.
Industry RankSector Rank
Dividend Yield N/A

ALPHATEC HOLDINGS INC

NASDAQ:ATEC (11/22/2024, 8:24:16 PM)

After market: 10.06 0 (0%)

10.06

-0.15 (-1.47%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap1.43B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -23.85%
ROE -799.73%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 69.47%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.77
Health
Industry RankSector Rank
Debt/Equity 23.65
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 2.32
Quick Ratio 1.15
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)15.23%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y28.61%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)27.22%
Revenue growth 3Y49.3%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y